Skip to main content
. 2026 Jul 13;17:1893876. doi: 10.3389/fendo.2026.1893876

Table 2.

Multivariable logistic regression and multivariable cox proportional hazards regression analyses of the association between serum adropin and prevalent/incident DKD.

Method/Level Model 1 Model 2 Model 3
OR/HR
(95% CI)
P-value OR/HR
(95% CI)
P-value OR/HR
(95% CI)
P-value
Logistic
adropin 0.82 (0.70,0.95) 8.84×10-3 0.82 (0.70, 0.96) 1.26×10-2 0.83(0.71,0.96) 1.53×10-2
Q1 Ref. Ref. Ref.
Q2 0.63 (0.32, 1.23) 1.85×10-1 0.64 (0.32, 1.24) 1.92×10-1 0.63 (0.31, 1.23) 1.83×10-1
Q3 0.50 (0.23, 1.01) 5.97×10-2 0.51 (0.24, 1.04) 7.27×10-2 0.53 (0.25, 1.08) 8.93×10-2
Q4 0.32 (0.12, 0.71) 8.29×10-3 0.34 (0.13, 0.75) 1.26×10-2 0.35 (0.14, 0.78) 1.52×10-2
P trend 4.13×10-3 6.82×10-3 9.07×10-3
Cox
adropin 0.88 (0.85, 0.91) 9.69×10-11 0.88 (0.85, 0.91) 9.61×10-11 0.88 (0.85, 0.91) 8.40×10-11
Q1 Ref. Ref. Ref.
Q2 0.84 (0.70, 1.02) 7.39×10-2 0.84 (0.70, 1.02) 6.91×10-2 0.84 (0.70, 1.01) 6.67×10-2
Q3 0.73 (0.60, 0.88) 1.09×10-3 0.75 (0.62, 0.91) 3.18×10-3 0.75 (0.62, 0.91) 3.34×10-3
Q4 0.46 (0.37, 0.57) 3.37×10-12 0.45 (0.36, 0.57) 2.77×10-12 0.45 (0.36, 0.56) 2.42×10-12
P trend 1.03×10-12 1.83×10-12 1.73×10-12

a Model 1 was an unadjusted model including only Adropin.

b Model 2 was adjusted for age, sex, body mass index (BMI), smoking status, and alcohol consumption.

c Model 3 was further adjusted for hypertension and medication use based on Model 2.